Key result
Higher CALLY index linked to ~39% lower CVD mortality vs lowest quartile.
Why the study?
The role of the C-reactive protein-albumin-lymphocyte (CALLY) index in predicting cardiovascular disease prognosis, particularly in the broader population, remained inadequately studied.
Does a higher CALLY index predict lower cardiovascular disease prevalence and mortality in the general adult US population?
Cohort (n=22,848)
Does a higher CALLY index predict lower cardiovascular disease prevalence and mortality in the general adult US population?
Hazard Ratio: 0.61 (95% CI 0.5–0.74)
Absolute Event Rate: 2.2% vs 4.6%
p-value: p=<0.001
A higher C-reactive protein–albumin–lymphocyte (CALLY) index is independently associated with lower cardiovascular disease prevalence and mortality in the US adult population, highlighting its utility as a predictive biomarker for early cardiovascular risk.
Higher CALLY index was associated with lower CVD mortality; leaves open incremental value for risk stratification.
Background The role of the C-reactive protein–albumin–lymphocyte (CALLY) index in predicting cardiovascular disease prognosis, particularly in the broader population, remains inadequately studied. Methods Data from 22,848 adults, collected between 1999 and 2010, were analyzed in this study. The association between the CALLY index and cardiovascular disease prevalence and mortality was examined using multivariate logistic regression and Cox proportional hazards models. Restricted cubic spline, Kaplan–Meier survival curves, time-dependent receiver operating characteristic curves, and subgroup and interaction tests were employed. Results Following adjustment for all covariates, a 1-unit rise in the ln CALLY index was correlated with an 11% reduction in cardiovascular disease prevalence (odds ratio = 0.89, 95% confidence interval: 0.85, 0.93) and a 15% decrease in the risk of cardiovascular disease mortality (hazard ratio = 0.85, 95% confidence interval: 0.81, 0.89). Compared with the lowest quartile, patients in the highest quartile of the ln CALLY index exhibited a 33% lower prevalence of cardiovascular disease (odds ratio = 0.67, 95% confidence interval: 0.57, 0.79) and a 39% reduced risk of cardiovascular disease mortality (hazard ratio = 0.61, 95% confidence interval: 0.50, 0.74). The time-dependent receiver operating characteristic curve showed that the ln CALLY index predicted the 1-year cardiovascular disease mortality with an area under the curve of 0.819 (95% confidence interval: 0.753, 0.885). Conclusions The CALLY index was significantly inversely associated with cardiovascular disease prevalence and mortality and provided reliable discriminatory capacity in predicting early mortality attributable to cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted a cohort in General population (n=22,848). Higher ln CALLY index (Highest quartile) vs. Lowest ln CALLY index (Lowest quartile) was evaluated on Cardiovascular disease mortality (HR 0.61, 95% CI 0.50-0.74, p=<0.001). Patients in the highest quartile of the ln CALLY index exhibited a 39% reduced risk of cardiovascular disease mortality compared to the lowest quartile (HR 0.61, 95% CI 0.50-0.74, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: